4SC to Present at Two Upcoming Investor Conferences
News Apr 17, 2012
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will be presenting at two investor conferences this week.
Dr Ulrich Dauer, Chief Executive Officer of 4SC AG, will give a company presentation at the Future Leaders in the Biotech Industry conference, which will be held on 20 April 2012 in New York City, USA.
The presentation of 4SC will begin at 9.00am (ET).
Enno Spillner, Chief Financial Officer of 4SC AG, will give a company presentation at the 3rd FCF Family-to-Family Day, an investor conference exclusively for family offices and HNIs (High Net Worth Individuals) on 19 April 2012 in Munich.
The presentation of 4SC will begin at 3.15pm (CET).
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE
Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until NowNews
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.READ MORE
Researchers Reveal How Superbug Secretes It’s ToxinNews
Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018